Testing effectiveness (Phase 2)UnknownNCT00343668What this trial is testingS-1 and Irinotecan Combination Chemotherapy for Advanced Gastric CancerWho this might be right forGastric Cancer Korean Cancer Study Group 44
Post-approval studies (Phase 4)UnknownNCT01665417What this trial is testingIcotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung AdenocarcinomaWho this might be right forEGFR Positive Non-small Cell Lung CancerAdenocarcinoma Betta Pharmaceuticals Co., Ltd. 100
Large-scale testing (Phase 3)Looking for participantsNCT07221253What this trial is testingRilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)Who this might be right forBiliary Tract Cancer AstraZeneca 1,100
Testing effectiveness (Phase 2)Study completedNCT00072579What this trial is testingSargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial TreatmentWho this might be right forLeukemia Wake Forest University Health Sciences
Large-scale testing (Phase 3)Not Yet RecruitingNCT06944496What this trial is testingDisitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric Carcinoma RemeGen Co., Ltd. 616
Post-approval studies (Phase 4)Study completedNCT02403986What this trial is testingAn Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the FaceWho this might be right forAged Skin Galderma R&D 53
Testing effectiveness (Phase 2)Study completedNCT02472054What this trial is testingTreatment of Familiar LymphohistiocytosisWho this might be right forHemophagocytic Lymphohistiocytosis (HLH) Assistance Publique - Hôpitaux de Paris 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT07176702What this trial is testingA Phase II Clinical Study of HLX22 in Combination With Trastuzumab and ChemotherapyWho this might be right forMetastatic PDACHER2-positive Status Shanghai Zhongshan Hospital 45
Very early researchUnknownNCT02853942What this trial is testingAutologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial SpasmWho this might be right forInjury of Facial Nerve, Unspecified Side, Initial Encounter Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)UnknownNCT03201146What this trial is testingApatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCWho this might be right forLung CancerNon Small Cell Lung CancerCombination Chemotherapy+1 more West China Hospital 48
Testing effectiveness (Phase 2)Study completedNCT00118183What this trial is testingDocetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+5 more National Cancer Institute (NCI) 62
Early research (Phase 1)Looking for participantsNCT04686305What this trial is testingPhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCWho this might be right forLocally Advanced or Metastatic Non-Small Cell Lung Cancer AstraZeneca 304
Testing effectiveness (Phase 2)Study completedNCT00001122What this trial is testingAn Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications CorrectlyWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 74
Testing effectiveness (Phase 2)UnknownNCT05721651What this trial is testingEfficacy and Safety of Fruquintinib in Combination With PD-1 Inhibitors as First-line Maintenance Therapy for Advanced HER-2 Negative Gastric Cancer: a Single-arm, Prospective, Exploratory Clinical StudyWho this might be right forGastric Cancer Wu Jun 60
Testing effectiveness (Phase 2)UnknownNCT04586088What this trial is testingApatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment FailureWho this might be right forNasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more Sun Yat-sen University 58
Not applicableStudy completedNCT01067794What this trial is testingChemotherapy in Treating Patients With Lung CancerWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 1,610
Post-approval studies (Phase 4)Study completedNCT01059422What this trial is testingRaltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected PatientsWho this might be right forHIV InfectionsTuberculosis Central Institute of Epidemiology, Moscow, Russia 10
Large-scale testing (Phase 3)Study completedNCT00154102What this trial is testingCetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)Who this might be right forEpidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer Merck KGaA, Darmstadt, Germany 1,221
Not applicableStudy completedNCT01220102What this trial is testingEfficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory AcneWho this might be right forAcne Galderma Laboratorium GmbH 3,113
Testing effectiveness (Phase 2)Looking for participantsNCT06486883What this trial is testingSafety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal SubtypeWho this might be right forAdvanced Breast CancerAdvanced Breast CarcinomaHormone Receptor Positive Breast Carcinoma MedSIR 200